Valued Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1K Sell
27
-5
-16% -$2.74K ﹤0.01% 256
2026
Q2
$16.8K Buy
32
+4
+14% +$2.24K 0.01% 225
2026
Q1
$15.7K Buy
28
+1
+4% +$641 0.01% 213
2025
Q4
$18.3K Buy
27
+1
+4% +$681 0.01% 168
2025
Q3
$16.6K Hold
26
– – 0.01% 171
2025
Q2
$13.9K Hold
26
– – 0.01% 183
2025
Q1
$10.9K Hold
26
– – 0.01% 213
2024
Q4
$10.8K Sell
26
-2
-7% -$877 0.01% 222
2024
Q3
$14.1K Hold
28
– – 0.01% 185
2024
Q2
$13.6K Buy
28
+3
+12% +$1.51K 0.01% 169
2024
Q1
$13.5K Buy
25
+4
+19% +$2.19K 0.01% 155
2023
Q4
$9.18K Buy
+21
New +$9.9K 0.01% 130

Other funds holding IDXX

Valued Wealth Advisors's IDXX Position: Q3 2026 in Review

Valued Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 16% in Q3 2026, selling an estimated $2.74K and leaving 27 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Valued Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.3K in Q4 2025. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Valued Wealth Advisors held 27 shares of Idexx Laboratories worth $14.1K as of Q3 2026.
  • Valued Wealth Advisors sold 5 Idexx Laboratories shares in Q3 2026, an estimated $2.74K.
  • Idexx Laboratories made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q3 2026, its #256 holding.
  • Valued Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
  • Valued Wealth Advisors's Idexx Laboratories position peaked at $18.3K in Q4 2025.
  • 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Valued Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.